A systematic review and meta-analysis for the effectiveness and safety of using acupoint Shui Gou (GV26)  by Hu, Xiao-Yang et al.
135 ICCMR 2015 Poster Presentation Abstracts
P5.029
The quality of clinical practice guidelines in
traditional medicine in Korea: appraisal
using the AGREE II instrument
Jiae Choi, Tae-Young Choi, Ju Ah Lee,
Ji Hee Jun, Myeong Soo Lee
Korea Institute of Oriental Medicine
Purpose: This study aimed to investigate the current Clin-
ical Practice Guidelines (CPGs) in traditional medicine (TM)
through evaluating the evidence-based CPGs in TM using the
Appraisal of Guidelines for Research and Evaluation (AGREE)
II instrument and to identify their quality to further enhance
the development and revision of CPGs.
Methods: A search was performed for guidelines in Korean
from inception until March 2014 in themajor Korean guideline
websites [the Korean Medical Guideline Information Centre
(KoMGI), the Korean Guideline Clearing House (KGC)], PubMed
and seven Korean electronic databases; the Association of
Korean Oriental Medicine (AKOM) was also consulted. Five
independent assessors rated the quality of each CPG using the
AGREE II instrument and calculated the mean score of each
AGREE item. The overall agreement amongst reviewers was
evaluated using the intra-class correlation coefﬁcient (ICC).
Results: We ﬁrst examined 17 CPGs for TM in Korean, and
only eight CPGs were consistent with the original aim of the
CPGs based on an underlying systematic review of the evi-
dence. The mean scores for each AGREE II domain were as
follows: 1) scope and purpose, 60.0% (range: 45.56-83.33%); 2)
stakeholder involvement, 56.11% (36.67–76.67%); 3) rigour of
development, 42.7% (18.33–70.0%); 4) clarity and presentation,
62.50% (44.44–81.11%); 5) applicability, 20.31% (12.5– 30.83%);
and 6) editorial independence, 44.58% (1.67–93.33%). All of the
CPGs were rated as “recommended with provisos or modiﬁ-
cations”. The ICC values for CPG appraisal using the AGREE II
ranged from 0.230 to 0.993.
Conclusion: The quality of CPGs for TM in Korea has
remained suboptimal according to the AGREE II Instrument
evaluation. Therefore, guideline developers in Korea should
make more of an effort to ensure high quality CPGs.
Contact: Jiae Choi, ksjiae@kiom.re.kr
http://dx.doi.org/10.1016/j.imr.2015.04.256
P5.030
A systematic review and meta-analysis for
the effectiveness and safety of using acupoint
Shui Gou (GV26)
Xiao-Yang Hu1, Esme Trevelyan1,
Qian-Yun Chai2, Cong-Cong Wang2,
Yu-Tong Fei2, Jian-Ping Liu2,
Nicola Robinson1
1 London South Bank University
2 Beijing University of Chinese Medicine
Purpose: This systematic review evaluates the effective-
ness and occurrence of adverse effects of using GV26 for a
variety conditions; and to determine the appropriate parame-
ters to inform its use in practice as an emergency and a revival
acupoint.
Methods: Twelve databases were searched from inception
to Oct 2013. Randomized controlled trials evaluating stimula-
tion of GV26 as a sole or as an adjunct to treatment for any
condition were included. Quality of reporting and method-
ology was assessed using STRICTA and the Cochrane risk of
bias tool. Meta-analysis was pooled with RevMan 5.2 software
(Protocol ID: CRD42013006528).
Results: Fifteen trials with 1590 patients were included.
Conditions investigated included shock, epilepsy, vascular
dementia, febrile seizures in children, post general anaesthe-
sia, acute low back strain, functional enuresis, and intractable
hiccups. The reporting quality and methodological quality of
all included trials was limited. Data from eleven trials were
pooled. Signiﬁcant favourable improvements were shown for
GV26 used in addition to other common acupoints as mea-
sured by efﬁcacy rate (RR 1.07, 95% CI [1.00, 1.14]; I2=5%); GV26
in addition to usual care increased systolic blood pressure (MD
6.09, 95% CI [3.57, 8.60]; I2=49%); and increased in diastolic
blood pressure (MD 8.60, 95% CI [6.10, 11.09]; I2=12%). No study
reported any adverse effects.
Conclusion: There appears to be evidence on the use of
GV26 on improving efﬁcacy rate in ALBS, functional enure-
sis and in tractable hiccups, and it appears to be effective in
increasing blood pressure, reducing heart rate during revival.
However, the ﬁndings should be interpreted with caution due
to the limited methodological quality of included trials. More
rigorous trials with good methodological design and strict
reporting of clinical effectiveness and adverse effects of GV26
are warranted.
Contact:Xiao-YangHu, hux2@lsbu.ac.uk / Nicola Robinson,
nicky.robinson@lsbu.ac.uk
* The abstract was admitted to and published in Acupunc-
ture and Related Therapies Volume 3, Issue 1, February 2015,
Pages 1–10.
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A Qualitative Study of Chinese Medical
Psychology in China: Implications for
Translation Beyond China
Sonya Pritzker
UCLA Department of Medicine
Purpose: The purpose of this anthropological study was
to examine the development of innovative forms of psycho-
logical care in Chinese medicine in China, and to assess the
“translatability” of such forms to integrative contexts in other
parts of the world.
Methods: This anthropological study utilized an ethno-
graphic approach involving participant observation, video-
recoding of doctor-patient interactions and treatments, and
interviews with both doctors and patients in the psychology
